The Racing Drug and Experimental Association announced on February 6 that its executive committee approved the RMTC’s scientific advisory committee to develop withdrawal guidelines for regulated screening limits. in the Equestrian Integrity and Safety Authority’s proposed anti-doping and drug control regulations. This work will be limited to drugs studied by the RMTC in the therapeutics category, which represent a subset of HISA-controlled drug substances and must be approved by the full board of directors by the end of this year. mid February.
Assuming approval from the Federal Trade Commission for HISA’s ADMC program, effective March 27, veterinarians and responsible persons (e.g. trainers) will be responsible responsible for determining an appropriate discontinuation interval for CMS administered to covered horses.
The SAC is conducting a rigorous analysis of the existing regulatory data for these therapeutic agents. This data, previously generated by the RMTC through a controlled substance monograph series, will be applied to the ADMC screening limits and detection time recently published by the FTC. Dr Michael Hardy, chief executive officer of RMTC explains, “This analysis will respond to the industry’s need for scientifically-sourced information to assist veterinarians and horsemen in making informed decisions. drug regulation and to avoid preventable errors. The RMTC guidelines are intended to promote compliance and will not conflict with HISA regulations.”
Alan Foreman, President and CEO of the Thoroughbred Riders Association and co-chairman of the RMTC, added: “The RMTC is a trusted and valuable resource in the industry when it comes to solving scientific challenges. about the proper treatment of our horses combined with the need to prescribe controls to protect the integrity of the sport and the safety and welfare of the horse. urged the RMTC to make this effort and are delighted that they have agreed to do so.The information provided by the RMTC is an important guide to assist our riders and veterinarians in complying with regulatory limits. new regulations imposed by HISA.”
With the current date of March 27, 2023 for the implementation of the FTC-approved ADMC regulations, SAC is working hard to make any and all information available before this date.
This press release has been edited by BloodHorse Staff for content and style.
